News & Updates

Stay connected with the latest news, updates, and clinical

Press Releases

Spirair Receives FDA Clearance for SeptAlign, the First and Only Minimally Invasive Therapy for Mechanical Correction of Nasal Septal Deviation

New therapy provides a minimally invasive option for ENTs to straighten minor deviations in septal cartilage and help address nasal airway obstruction.
Read More

Spirair Announces Appointment of Chief Executive Officer

Spirair Announces Appointment of Chief Executive Officer Spirair is entering its next stage of growth as it prepares for commercialization.
Read More

Media Coverage

Explore additional content

What Spirair learned about polydioxanone in its innovative use of the absorbable polymer for a new implant

Read More
Nose knows - close up image of nose

Nose-knows: How a Stanford research project turned into a way to fix a deviated septum

Leaders of a Peninsula medical device startup believe they can straighten out nasal septal deviations for potentially hundreds of thousands of people
Read More

Connect With Us

Enter your contact information below to receive more information or request a demo.

Name(Required)
This field is for validation purposes and should be left unchanged.

SPIRAIRTM and SEPTALIGNTM are trademarks of Spirair Inc.
MRK-010-A
Copyright © 2024 Spirair, Inc.